» Articles » PMID: 7891375

Linkage of Hereditary Haemorrhagic Telangiectasia to Chromosome 9q34 and Evidence for Locus Heterogeneity

Overview
Journal J Med Genet
Specialty Genetics
Date 1994 Dec 1
PMID 7891375
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder with unknown pathophysiology that is characterised by arteriovenous lesions and recurrent haemorrhage in virtually every organ. Linkage of HHT to markers on chromosome 9q has recently been reported. In this study we report confirmation of this localisation in three unrelated families of Dutch origin. A fourth unrelated HHT family, in which considerably fewer pulmonary arteriovenous malformations (PAVM) were present, yielded evidence for non-linkage to this region. We conclude that HHT is a genetically heterogeneous disorder and our results indicate that the presence of PAVM may be more common in patients with a chromosome 9 linked form of HHT than in patients with the non-linked form.

Citing Articles

High risk of ischaemic stroke amongst patients with hereditary haemorrhagic telangiectasia.

Kofoed M, Torring P, Christensen A, Lange B, Kjeldsen A, Nielsen T Eur J Neurol. 2023; 31(2):e16128.

PMID: 37955551 PMC: 11235815. DOI: 10.1111/ene.16128.


Founder Effects in Hereditary Hemorrhagic Telangiectasia.

Major T, Gindele R, Balogh G, Bardossy P, Bereczky Z J Clin Med. 2021; 10(8).

PMID: 33919892 PMC: 8070971. DOI: 10.3390/jcm10081682.


An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia.

Yu Q, Shen X, Li Y, Li R, Li J, Luo Y PLoS One. 2013; 8(2):e58031.

PMID: 23460919 PMC: 3584037. DOI: 10.1371/journal.pone.0058031.


CT Manifestations of Osler-Weber-Rendu Syndrome in Liver: Report of Three Cases.

Chuan-Qiang Q, Shou-Gang G, Yan H, Yu-Xin C J Clin Imaging Sci. 2012; 2:26.

PMID: 22754740 PMC: 3385500. DOI: 10.4103/2156-7514.96541.


Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.

Sadick H, Sadick M, Gotte K, Naim R, Riedel F, Bran G Wien Klin Wochenschr. 2006; 118(3-4):72-80.

PMID: 16703249 DOI: 10.1007/s00508-006-0561-x.


References
1.
McCabe W, KELLY Jr A . Management of epistaxis in Osler-Weber-Rendu disease: recurrence of telangiectases within a nasal skin graft. Plast Reconstr Surg. 1972; 50(2):114-8. DOI: 10.1097/00006534-197208000-00002. View

2.
Bird R, HAMMARSTEN J, Marshall R, Robinson R . A family reunion: a study of hereditary hemorrhagic telangiectasia. N Engl J Med. 1957; 257(3):105-9. DOI: 10.1056/NEJM195707182570303. View

3.
Reilly P, Nostrant T . Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol. 1984; 79(5):363-7. View

4.
Lathrop G, Lalouel J, Julier C, Ott J . Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984; 81(11):3443-6. PMC: 345524. DOI: 10.1073/pnas.81.11.3443. View

5.
Sensi A, Abbasciano V, Balboni A, Levato F, Baricordi O . Hereditary hemorrhagic telangiectasy (HHT) and HLA. Tissue Antigens. 1986; 28(5):275-7. DOI: 10.1111/j.1399-0039.1986.tb00496.x. View